Effects of Levosimendan on Markers of Left Ventricular Diastolic Function and Neurohormonal Activation in Patients With Advanced Heart Failure

This publication has 14 references indexed in Scilit:

• Effects of levosimendan on circulating pro-inflammatory cytokines and soluble apoptosis mediators in patients with decompensated advanced heart failure
  The American Journal of Cardiology, 2004
• Levosimendan: Implications for Clinicians
  The Journal of Clinical Pharmacology, 2003
• Utility of B-Natriuretic Peptide in Detecting Diastolic Dysfunction
  Circulation, 2002
• Pharmacodynamics and Safety of a New Calcium Sensitizer, Levosimendan, and Its Metabolites during an Extended Infusion in Patients with Severe Heart Failure
  The Journal of Clinical Pharmacology, 2002
• Acute Hemodynamic and Clinical Effects of Levosimendan in Patients With Severe Heart Failure
  Circulation, 2000
• Clinical Utility of Doppler Echocardiography and Tissue Doppler Imaging in the Estimation of Left Ventricular Filling Pressures
  Circulation, 2000
• Influence of the Novel Inotropic Agent Levosimendan on Isometric Tension and Calcium Cycling in Failing Human Myocardium
  Circulation, 1998
• Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction
  American Heart Journal, 1998
• Doppler Tissue Imaging: A Noninvasive Technique for Evaluation of Left Ventricular Relaxation and Estimation of Filling Pressures
  Journal of the American College of Cardiology, 1997
• Prognostic value of Doppler transmitral flow patterns in patients with congestive heart failure
  Journal of the American College of Cardiology, 1994